400
FES Antibody (pTyr713 + pSer716)- Dylight 594
- SKU:
- 400-SPC-980D-DY594-GEN
- Availability:
- IN STOCK
Additional Information
| Size: | 100 µl | 
| Target: | FES (pTyr713 + pSer716) | 
| Conjugate: | Dylight 594 | 
| Research Area: | Cardiovascular System | Angiogenesis | Cardiovascular Growth Factors | Adhesion / Extracellular Matrix | Integrins | Cell Signaling | Protein Phosphorylation | Tyrosine Kinases | FAK / PYK | Cell Signaling | Extracellular Matrix (ECM) | Focal Adhesio | 
| Alternative Name: | FPS Antibody, c-fes/fps protein Antibody, cFES Antibody, FES Antibody, Feline sarcoma (Snyder Theilen) viral (v fes)/Fujinami avian sarcoma (PRCII) viral (v fps) oncogene homolog Antibody, feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami Antibo | 
| Category: | Antibodies | 
| Product Type: | Polyclonal Antibody | 
| Immunogen: | A phospho-specific peptide corresponding to residues surrounding Tyr713 and Ser716 of human FES (AA711-720) | 
| Immunogen Species: | Human | 
| Applications: | WB, AM | 
| Host: | Rabbit | 
| Isotype: | N/A | 
| Species Reactivity: | Human | 
| Antibody Dilution: | WB (1:250); optimal dilutions for assays should be determined by the user. | 
| Purification: | Peptide Affinity Purified | 
| Storage Buffer: | PBS pH7.4, 50% glycerol, 0.025% Thimerosal | 
| Concentration: | N/A | 
| Specificity: | Detects 93.471 kDa. | 
| Storage: | -20ºC | 
| Shipping: | Blue Ice or 4ºC | 
| Certificate of Analysis: | A 1:250 dilution of SPC-980 was sufficient for detection of FES (pTyr713 + pSer716) in 10 µg of human placenta lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. | 
| Cellular Localization: | Cell Junctions, Focal Adhesion, Cell Membrane, Cytoplasm, Cytosol, Golgi Apparatus | 
| Tissue Specificity: | N/A | 
| Accession Number: | NP_001996 | 
| Gene ID: | 2243 | 
| Swiss-Prot: | P07332 | 
| Field of Use: | For in vitro research use only. | 
 
             
             
             
             
             
             
             
             
             
            